|
We have more features on the following subjects:
NHS,
stock market,
PR,
R&D,
advertising and
careers.
|
My product in 2008 - PA or PR?
|
14-Jun-2008
|
 As Plato said: “The price good men pay for indifference to public affairs is to be ruled by evil men.” Why, asks Nick May, is public affairs so often the long, lost second cousin in the marketing mix?
Read more...
|
|
Are you media-savvy enough?
|
13-Jun-2008
|
 The two words 'media relations' have caused much discussion within pharmaceutical companies over the years. Cherry Wood defends the industry's right to be innovative - albeit code-abiding - in the way it creates awareness
Read more...
|
|
Taking a leaf from their book
|
12-Jun-2008
|
 Can it be right, ask Neil and Tom Kendle, that online bookseller Amazon knows more about the interests of each of its 100 million customers than the average drug company knows about most of its key opinion leaders?
Read more...
|
|
Can UK pharma become a world player?
|
11-Jun-2008
|
 A recent report from PricewaterhouseCoopers predicts that the global pharma market will more than double in value by 2020. John Clare asks if UK pharma is heading for relegation or can it fight off fierce competition to make the premier division?
Read more...
|
|
A refining process
|
14-May-2008
|
 Key account management is not a revolution but a distillation of the marketing mix that can help sales forces deal with NHS changes
Read more...
|
|
Creating a classic
|
10-Apr-2008
|
 Pharma could benefit from emulating the style and thinking behind successful consumer ads to make an impact
Read more...
|
|
Getting a Buzz
|
10-Apr-2008
|
 Managers must be sensitive to the emotional status of their staff if they want to get the best out of them
Read more...
|
|
Growth Spurt
|
10-Apr-2008
|
 Pharma must change its supply chain model to maximise on future growth opportunities resulting from a global surge in product demand
Read more...
|
|
As Brian Gunson and Sarah Hart explain, Web 2.0 allows marketers to have the relationship they’ve always said they wanted… open and transparent, with two-way conversations
It’s a hotly debated subject and individual cases make headline news. Isn’t it time, asks Liz Shanahan, for pharma to accept that patient top-ups may be inevitable?
Employers must adapt their management styles and culture to get the best performance from their staff
The emergence of medtech brings a seed of hope to healthcare
To meet market access challenges, pharma must adopt an integrated, streamlined approach
Why is pharma still tentative in its use of e-marketing channels?
The NHS' new patient-driven choice agenda requires detailed, highly targeted information analysis
